Jeffrey Price

A Randomized, Controlled Study to Investigate the Analgesic Efficacy of Single Doses of the Cannabinoid Receptor-2 Agonist GW842166, Ibuprofen or Placebo in Patients With Acute Pain Following Third Molar Tooth Extraction

Thor Ostenfeld, Jeffrey Price, Massimo Albanese et al. · Clinical Journal of Pain · 2011 · 122 citations

Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial

Vincent Meininger, Pierre-François Pradat, Andrea M. Corse et al. · PLoS ONE · 2014 · 86 citations · Full text

Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab

Isabelle Pouliquen, Oliver Kornmann, Sharon V. Barton et al. · International Journal of Clinical Pharmacology and Therapeutics · 2015 · 83 citations · Full text

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 82 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Clinical Neurology +4

Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study

Joanne Ellis, André van Maurik, Léa Fortunato et al. · British Journal of Clinical Pharmacology · 2018 · 42 citations · Full text